Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Public ClinicalTrials.gov record NCT00088504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Study of Merimepodib in Combination With Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects With Chronic Hepatitis C Non-Responsive to Prior Therapy With Pegylated Interferon Alfa and Ribavirin
Study identification
- NCT ID
- NCT00088504
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vertex Pharmaceuticals Incorporated
- Industry
- Enrollment
- 315 participants
Conditions and interventions
Conditions
Interventions
- Merimepodib Drug
- PEG-Interferon-alpha 2a (Pegasys®) Drug
- Ribavirin (Copegus®) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2004
- Primary completion
- Not listed
- Completion
- Sep 30, 2006
- Last update posted
- Dec 20, 2007
2004 – 2006
United States locations
- U.S. sites
- 67
- U.S. states
- 28
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Joseph L. Cochran, M.D. | Birmingham | Alabama | 35209 | — |
| Suresh Karne, M.D., Ph.D. | Huntsville | Alabama | 35801 | — |
| Vijayan Balan, M.D. | Phoenix | Arizona | 85054 | — |
| Michael P. DeMicco, M.D. | Anaheim | California | 92801 | — |
| Prahalad B. Jajodia, M.D. | Fresno | California | 93703 | — |
| F. Fred Poordad, M.D. | Los Angeles | California | 90095-7054 | — |
| Ramsey Cheung, M.D. | Palo Alto | California | 94304 | — |
| Myron J. Tong, M.D., Ph.D. | Pasadena | California | 91105 | — |
| Michael T. Bennett, M.D. | San Diego | California | 92123 | — |
| Lisa M. Nyberg, M.D. | San Diego | California | 92154 | — |
| Natalie Bzowej, M.D. | San Francisco | California | 94115 | — |
| Marcelo Kugelmas, M.D. | Englewood | Colorado | 80113 | — |
| Herbert L. Bonkovsky, M.D. | Farmington | Connecticut | 06030 | — |
| Eugene R. Schiff, M.D. | Miami | Florida | 33136 | — |
| Jawahar L. Taunk, M.D. | Palm Harbor | Florida | 34684 | — |
| Arnold L. Lentnek, M.D. | Marietta | Georgia | 30060 | — |
| Ellen B. Hunter, M.D. | Boise | Idaho | 83702 | — |
| Steven L. Flamm, M.D. | Chicago | Illinois | 60611 | — |
| Helen Te, M.D. | Chicago | Illinois | 60637 | — |
| Gerald J. Mingoletti, M.D. | Oak Forest | Illinois | 60452 | — |
| Donald R. Graham, M.D. | Springfield | Illinois | 62703 | — |
| Alvaro G. Koch, M.D. | Lexington | Kentucky | 40536 | — |
| Shaban Faruqui, M.D. | Baton Rouge | Louisiana | 70808 | — |
| Robert M. Be, M.D. | Baton Rouge | Louisiana | 70809 | — |
| Bal Raj Bhandari, M.D. | Monroe | Louisiana | 71201 | — |
| Luis A. Balart, M.D. | New Orleans | Louisiana | 70115 | — |
| Robert Perrillo, M.D. | New Orleans | Louisiana | 70121 | — |
| Michael Epstein, M.D. | Annapolis | Maryland | 21401 | — |
| Natarajan Ravendhran, M.D. | Baltimore | Maryland | 21229 | — |
| Mark Sulkowski, M.D. | Baltimore | Maryland | 21287 | — |
| Milton J. Koch, M.D. | Silver Spring | Maryland | 20901 | — |
| David N. Schwartz, M.D. | Attleboro | Massachusetts | 02703 | — |
| Nezam Afdhal, M.D. | Boston | Massachusetts | 02215 | — |
| Lawton Shick, M.D. | Worcester | Massachusetts | 01655 | — |
| Stuart C. Gordon, M.D. | Detroit | Michigan | 48202 | — |
| John B. Gross, M.D. | Rochester | Minnesota | 55905-0002 | — |
| Jeffrey Rank, M.D. | Saint Paul | Minnesota | 55446 | — |
| Adrian Di Bisceglie, M.D. | St Louis | Missouri | 63104 | — |
| William C. Sloan | Florham Park | New Jersey | 07932 | — |
| Rajendra Prasad Gupta, M.D. | Trenton | New Jersey | 08618 | — |
| David Eric Bernstein, M.D. | Manhasset | New York | 11030 | — |
| Ira M. Jacobson, M.D. | New York | New York | 10021 | — |
| Douglas T. Dieterich, M.D. | New York | New York | 10029 | — |
| Robert Reindollar, M.D. | Charlotte | North Carolina | 28207 | — |
| Andrew Muir, M.D. | Durham | North Carolina | 27710 | — |
| John E. Poulous, M.D. | Fayetteville | North Carolina | 28304 | — |
| Mark E. Jonas, M.D. | Cincinnati | Ohio | 45219 | — |
| Harvey A. Tatum, M.D. | Tulsa | Oklahoma | 74104 | — |
| George Koval, M.D. | Portland | Oregon | 97225 | — |
| Jill P. Smith, M.D. | Hershey | Pennsylvania | 17033 | — |
| Victor Araya, M.D. | Philadelphia | Pennsylvania | 19141 | — |
| Peter J. Molloy, M.D. | Pittsburgh | Pennsylvania | 15224 | — |
| James Scott Strohecker, M.D. | Columbia | South Carolina | 29203 | — |
| Lawrence D. Wruble, M.D. | Memphis | Tennessee | 38120 | — |
| Ronald Pruitt, M.D. | Nashville | Tennessee | 37205 | — |
| Gary L. Davis, M.D. | Dallas | Texas | 75246 | — |
| William M. Lee, M.D. | Dallas | Texas | 75390-9016 | — |
| George G. Burnazian, M.D. | Houston | Texas | 77004 | — |
| Rise Stribling, M.D. | Houston | Texas | 77030 | — |
| Eric J. Lawitz, M.D. | San Antonio | Texas | 78215 | — |
| Daniel Pambianco, M.D. | Charlottesville | Virginia | 22911 | — |
| Vinod Rustgi, M.D. | Fairfax | Virginia | 22031-5216 | — |
| Mitchell Shiffman, M.D. | Richmond | Virginia | 23249 | — |
| Robert A. Wohlman, M.D. | Bellevue | Washington | 98004-3049 | — |
| Robert L. Carithers, M.D. | Seattle | Washington | 98195 | — |
| David Winters McEniry, M.D. | Tacoma | Washington | 98405 | — |
| Michael F. Lyons II, M.D. | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2007 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00088504 live on ClinicalTrials.gov.